Early Intervention May Reduce Breast CA-Related Lymphedema

Share this content:
Early Intervention May Reduce Breast CA-Related Lymphedema
Early Intervention May Reduce Breast CA-Related Lymphedema

FRIDAY, May 4, 2018 (HealthDay News) -- For breast cancer patients undergoing treatments that are high risk for the development of breast cancer-related lymphedema (BCRL), evaluations with bioimpedance spectroscopy (BIS) allows for early detection of BCRL that is responsive to conservative interventions, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held from May 2 to 6 in Orlando, Fla.

Lyndsey Kilgore, M.D., from the University of Kansas Health System in Kansas City, and colleagues evaluated 146 breast cancer patients with unilateral disease undergoing treatments that are high risk for the development of BCRL. Patients with subclinical lymphedema diagnosed by a BIS result of two standard deviations above baseline from preoperative assessment were started on at-home conservative interventions (compression sleeve garment and self-massage).

The researchers found that 34 percent of patients developed subclinical lymphedema, identified by elevated BIS scores, and were initiated on self-directed treatment. At last follow-up, 82 percent of these patients had resolution of elevated measurements. Nine patients had continued elevated measurements and were referred to outpatient complete decongestive therapy (clinically persistent BCRL incidence, 18 percent). On final surgical pathology, patients with persistent BCRL had significant nodal burden; eight of the nine had N2 or N3 disease. Six of these nine patients have died due to breast cancer.

"Early detection with patient directed interventions for subclinical and early lymphedema can improve patient outcomes and decrease the risk of chronic irreversible lymphedema," the authors write.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »